|
Real-world patient pathway of care for diffuse large B-cell lymphoma (DLBCL). |
|
|
|
Stock and Other Ownership Interests - Roche |
|
|
|
Stock and Other Ownership Interests - Roche |
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Pathedex |
Honoraria - Caris Life Sciences; Roche |
Consulting or Advisory Role - Caris Life Sciences; Roche |
Research Funding - Roche (Inst) |
|
|
Employment - Roche/Genentech |
Stock and Other Ownership Interests - AstraZeneca |